Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales @ radiantinsights. com Web: http:// www. radiantinsights. com /
� Table 14: Respiratory Disorders Therapeutics Market, Global, Approved Indications for Singulair, 2016 43
� Table 15: Respiratory Disorders Therapeutics Market, Global, Approved Indications for Flixotide, 2016 46
� Table 16: Respiratory Disorders Therapeutics Market, Global, Approved Indications for Ventolin, 2016 47
� Table 17: Respiratory Disorders Therapeutics Market, Global, Approved Indications for Kalydeco, 2016 48
� Table 18: Respiratory Disorders Therapeutics Market, Global, Approved Indications for Pulmozyme, 2016 50
� Table 19: Respiratory Disorders Therapeutics Market, Global, Approved Indications for Esbriet, 2016 51
List of Figures:
� Figure 1: Respiratory Disorders Therapeutics Market, Global, Epidemiology Patterns for Asthma, 2015-2023 12
� Figure 2: Respiratory Disorders Therapeutics Market, Global, Epidemiology Patterns for COPD, 2015-2023 13
� Figure 3: Respiratory Disorders Therapeutics Market, Global, Epidemiology Patterns for Idiopathic Pulmonary Fibrosis, 2015-2023 14
� Figure 4: Respiratory Disorders Therapeutics Market, Global, Epidemiology Patterns for Cystic Fibrosis, 2015-2023 15
� Figure 5: Respiratory Disorders Therapeutics Market, Clinical Courses of IPF 30
� Figure 6: Respiratory Disorders Therapeutics Market, Progression of CF 31
� Figure 7: Respiratory Disorders Therapeutics Market, Global, Key Marketed Products and Approved Indications, 2016 37
� Figure 8: Respiratory Disorders Therapeutics Market, Global, Annual Revenues for Advair($ bn), 2006-2022 39
� Figure 9: Respiratory Disorders Therapeutic Market, Global, Annual Revenues for Spiriva($ bn), 2006-2022 41
� Figure 10: Respiratory Disorders Therapeutics Market, Global, Annual Revenues for Symbicort($ bn), 2006-2022 43
� Figure 11: Respiratory Disorders Therapeutics Market, Global, Annual Revenues for Singulair($ bn), 2006-2022 45
� Figure 12: Respiratory Disorders Therapeutics Market, Global, Annual Revenues for Flixotide($ m), 2006-2022 46
� Figure 13: Respiratory Disorders Therapeutics Market, Global, Annual Revenues for Ventolin($ m), 2006-2022 48
� Figure 14: Respiratory Disorders Therapeutics Market, Global, Annual Revenues for Kalydeco($ bn), 2012-2022 49
� Figure 15: Respiratory Disorders Therapeutics Market, Global, Annual Revenue for Pulmozyme($ m), 2006-2022 51
https
:// www. facebook. com / RadiantInsights
https:// www. linkedin. com / company / radiant-insights https:// twitter. com / radiantinsights
https:// plus. google. com /+ Radiantinsights